Active Mental Health Genetics & Molecular Biology

Depression Genetics in Africa (DepGenAfrica)

In plain English

AI plain-English summary

A network of African and UK researchers is collecting and analysing genetic data from thousands of people with depression across multiple African countries, where almost no such data currently exists. This matters because nearly all large-scale genetic studies of depression have been done in people of European ancestry. The findings may not apply to African populations, yet depression is a leading cause of disability worldwide, and health disparities are growing. Without data from African cohorts, clinicians cannot know whether genetic risk scores or biological insights from European studies are relevant to African patients. If the project succeeds, it will reveal whether the genetic architecture of depression is similar across African countries and whether it mirrors European patterns. This could eventually improve risk prediction and treatment targeting for people of African ancestry. In the longer term, the network and research capacity built through this work will enable future studies of other psychiatric conditions in African populations. The project is primarily fundamental science—it asks a basic question about the biology of depression across human populations. But that knowledge is a prerequisite for any future clinical applications, from more accurate diagnostics to targeted therapies, in populations that have been systematically excluded from psychiatric genetics.

View original technical description
Background: rapid advances in our understanding of psychiatric disorder genetics within European ancestries are leading to mechanistic insights, more accurate risk stratification and stronger causal inferences, but there is growing concern that these findings may not generalise to African ancestries and those who reside in low and middle income countries. We need to urgently address this knowledge gap if we are to reduce growing health disparities. Vision: drawing on the substantial strengths of the UK Psychiatric Genomics Consortium (PGC) and a network of African investigators, we will develop processes for rapid sample collection and address critical scientific and clinical questions about the genetic architecture of depression in non-European populations. Research plans: using state-of-the-art ancestry-aware genetic methods, we will address whether the genetic architecture of major depressive disorder in different African countries is similar and whether it mirrors that of European ancestry populations. We will develop a network of UK and African partners in the best clinical research practices. We will adopt a pragmatic approach to data collection and analysis through a combination of new sample collections and genotyping and analysing existing samples; building capacity at each stage of the research process.

View the original record at the funder ↗

Researchers

Amelia Crampin (EPMC Awardee)Andrew McIntosh (EPMC Awardee)Chisomo Msefula (EPMC Awardee)Gerome Breen (EPMC Awardee)James Walters (EPMC Awardee)Michele Ramsay (EPMC Awardee)Solomon Teferra (EPMC Awardee)Taiwo Sheikh (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Genetic risk for major depressive disorder among three ethnically diverse African cohorts
The genetics of depression in diverse populations
Depression in diverse populations: Unravelling the interplay between genes and environment
Genetic risk and interaction between epilepsy and psychiatric conditions (autism and psychosis)
Identifying genomic and phenotypic risk factors for the clinical progression of depressive symptoms

Original classification

Collaborative Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.